Guest Contributors

Daniel Levner Co-Founder and Chairman of the Scientific Advisory Board, Sight Dx
Ivan Liachko, CEO & CSO of Phase Genomics
Founder, Rare Genomics Institute
Director of the Bioinformatics Core at UC Davis Genome Center
Shirley Liu, Professor of Biostatisitcs at Harvard, Co-Director of the Center for Fuctional Cancer Epigenetics at the Dana Farber Cancer Institute
Terry Lo, CEO at Vizgen
Matt Loose, Professor of Developmental and Computational Biology, Faculty of Medicine & Health Sciences, University of Nottingham
Professor, University of Illinois
CEO, Assay Depot
Clinical Services Lab Director at HudsonAlpha Institute for Biotechnology
Sandy Macrae, CEO of Sangamo
President and CEO, BayBio
Science Comedian
Deputy Office Director of Personalized Medicine, OIR, FDA
Professor and Head, Department of Medical Genetics, University of British Columbia
Annie Martin, SVP, Global Head of Precision Medicine, Novartis
Chief Operating Officer, IDT
former CEO, Pacific Biosciences
Rodrigo Martinez, Chief Marketing and Design Officer at Veritas
Program Chair, PMWC
Founder, Science Futures
President and CEO, My Gene Counsel
VP, Boston Healthcare